top of page
The Professional Network for Healthcare Experts
FDA expands Camzyos approval to paediatric patients with obstructive hypertrophic cardiomyopathy
The FDA has expanded Camzyos approval to paediatric patients with symptomatic obstructive hypertrophic cardiomyopathy who weigh at least 30kg.
nuaxia
22 hours ago1 min read
Bristol Myers Squibb ends $380 million Cellares CAR-T manufacturing partnership
BMS concluded that Cellares’ automated Cell Shuttle platform could not meet the specific requirements for commercial Breyanzi production, prompting Cellares to cut around 100 positions.
nuaxia
Aug 273 min read
FDA clears Wandercraft’s Eve self-balancing exoskeleton for personal use in adults with spinal cord injury
The clearance extends Wandercraft’s self-balancing exoskeleton technology beyond supervised rehabilitation, allowing eligible adults with spinal cord injuries to use Eve for hands-free upright mobility and daily activities with a trained companion.
nuaxia
Aug 142 min read
FDA grants accelerated approval to Zenbexus combination for previously treated multiple myeloma
The approval provides adults who have received at least one prior line of therapy with a new iberdomide-based combination, supported by higher minimal residual disease-negative complete response rates than the comparator regimen in EXCALIBER-RRMM.
nuaxia
Aug 142 min read
bottom of page